M. Lynn Weir

535 total citations
12 papers, 396 citations indexed

About

M. Lynn Weir is a scholar working on Molecular Biology, Cell Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Lynn Weir has authored 12 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Lynn Weir's work include Muscle Physiology and Disorders (3 papers), Cellular transport and secretion (3 papers) and Heart Failure Treatment and Management (2 papers). M. Lynn Weir is often cited by papers focused on Muscle Physiology and Disorders (3 papers), Cellular transport and secretion (3 papers) and Heart Failure Treatment and Management (2 papers). M. Lynn Weir collaborates with scholars based in Canada, United States and Australia. M. Lynn Weir's co-authors include William S. Trimble, Amira Klip, John Muschler, Kevin P. Campbell, Mina J. Bissell, Michael D. Henry, Akiko Onishi, Leonard J. Foster, Jeremy A. Scott and Ann F. Chambers and has published in prestigious journals such as Annals of Internal Medicine, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

M. Lynn Weir

11 papers receiving 395 citations

Peers

Countries citing papers authored by M. Lynn Weir

Since Specialization

Citations

This map shows the geographic impact of M. Lynn Weir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lynn Weir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lynn Weir more than expected).

Fields of papers citing papers by M. Lynn Weir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Lynn Weir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lynn Weir. The network helps show where M. Lynn Weir may publish in the future.

Co-authorship network of co-authors of M. Lynn Weir

This figure shows the co-authorship network connecting the top 25 collaborators of M. Lynn Weir. A scholar is included among the top collaborators of M. Lynn Weir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Lynn Weir. M. Lynn Weir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors 2025 ·JAMA Internal Medicine ·(unknown), Joel G. Ray, Kevin Yau, Nivethika Jeyakumar, (unknown), Bin Luo, David Z.I. Cherney, Ziv Harel, Gregory L. Hundemer, Thomas A. Mavrakanas, Amber O. Molnar, Ayodele Odutayo, Jeffrey Perl, Ann Young, David M. Charytan, M. Lynn Weir, (unknown)	2
2	Risk for Scrotal Surgery After Laparoscopic Donor Nephrectomy 2025 ·Annals of Internal Medicine ·Amit X. Garg, Eric McArthur, Jessica M. Sontrop, Neil Boudville, Dervla M. Connaughton, Meaghan S. Cuerden, Liane S. Feldman, Ngan N. Lam, Krista L. Lentine, (unknown), Chirag R. Parikh, Dorry L. Segev, Alp Şener, Graham Smith, Carol Wang, M. Lynn Weir, (unknown), Ann Young, Kyla L. Naylor	0
3	Adverse events with co‐prescription of angiotensin receptor blockers and clarithromycin compared to azithromycin: A population‐based retrospective cohort study 2025 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Nicholas C. Tonial, Sarah E. Bota, (unknown), Flory T. Muanda, Bradley L. Urquhart, M. Lynn Weir	1
4	Dystroglycan loss disrupts polarity and β-casein induction in mammary epithelial cells by perturbing laminin anchoring 2006 ·Journal of Cell Science ·M. Lynn Weir, (unknown), Michael D. Henry, Akiko Onishi, Kevin P. Campbell, Mina J. Bissell, John Muschler	78
5	Dystroglycan loss disrupts polarity and beta-casein induction in mammary epithelial cells by perturbing laminin anchoring. 2006 ·PubMed ·M. Lynn Weir, (unknown), Michael D. Henry, Akiko Onishi, Kevin P. Campbell, Mina J. Bissell, John Muschler	25
6	Dystroglycan: Emerging Roles in Mammary Gland Function 2003 ·Journal of Mammary Gland Biology and Neoplasia ·M. Lynn Weir, John Muschler	18
7	VAP-A Binds Promiscuously to both v- and tSNAREs 2001 ·Biochemical and Biophysical Research Communications ·M. Lynn Weir, (unknown), Amira Klip, William S. Trimble	76
8	A Functional Role for VAP‐33 in Insulin‐Stimulated GLUT4 Traffic 2000 ·Traffic ·Leonard J. Foster, M. Lynn Weir, (unknown), (unknown), William S. Trimble, Amira Klip	54
9	Identification of a human homologue of the vesicle-associated membrane protein (VAMP)-associated protein of 33 kDa (VAP-33): a broadly expressed protein that binds to VAMP 1998 ·Biochemical Journal ·M. Lynn Weir, Amira Klip, William S. Trimble	80
10	Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissue 1998 ·American Journal of Physiology-Heart and Circulatory Physiology ·Jeremy A. Scott, M. Lynn Weir, Sylvia M. Wilson, Jim W. Xuan, Ann F. Chambers, David G. McCormack	48
11	Lack of biologic activity or specific binding of amino-terminal pro-ANP segments in the rat 1994 ·Regulatory Peptides ·M. Lynn Weir, U. Honrath, T.G. Flynn, H. Sonnenberg	6
12	Characterization of binding sites in rat for A, B and C-type natriuretic peptides 1993 ·Regulatory Peptides ·M. Lynn Weir, Stephen C. Pang, T. Geoffrey Flynn	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact